ATHIRA PHARMA INC. - COMMON STOCK
0.7138
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.0162
-2.22%
Today's range
0.6928 - 0.7472
ISIN
N/A
Source
NASDAQ
-
17 Jun 2021 17:00:00 By Nasdaq GlobeNewswire
-
14 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at Upcoming Investor Conferences
09 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma Appoints Mark Worthington as General Counsel
01 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at Upcoming Investor Conferences
26 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
13 May 2021 16:02:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
21 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2021 07:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2021 16:02:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at Stifel’s 3rd Annual CNS Conference
24 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
23 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
08 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
02 Mar 2021 07:00:02 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares
10 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Pricing of Public Offering of Common Stock
20 Jan 2021 19:35:44 By Nasdaq GlobeNewswire
-
Athira Pharma Announces Proposed Public Offering of Common Stock
19 Jan 2021 07:59:37 By Nasdaq GlobeNewswire
-
Athira Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 Jan 2021 07:30:00 By Nasdaq GlobeNewswire